This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Diagenode S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Clément Cassart: Innovator in DNA Methylation Detection
Introduction
Clément Cassart is a notable inventor based in Vaux-et-Borset, Belgium. He has made significant contributions to the field of molecular biology, particularly in the detection of DNA methylation status. His innovative approach has the potential to enhance diagnostic and treatment methodologies for various disorders.
Latest Patents
Clément Cassart holds a patent for the "Detection of methylation status of a DNA sample." This invention provides methods for quantitative analysis of methylation content in a test sample. The method employs an internal control within the same test sample and an external control within a reference sample to minimize sources of random variability. The internal control corrects for variability arising from conducting separate amplifications, while the external control addresses variability between amplification at different loci. The steps for processing and analyzing the test sample can occur in a single reaction vessel, facilitating automation of the assay. The information generated regarding methylation content can be utilized in diagnosing and treating disorders, as well as for forensic purposes among other applications. Clément Cassart has 1 patent to his name.
Career Highlights
Clément Cassart is associated with Diagenode S.A., a company known for its advancements in epigenetics and molecular biology. His work at Diagenode has allowed him to contribute to cutting-edge research and development in the field.
Collaborations
One of his notable coworkers is Renaud Schoemans, with whom he collaborates on various projects related to DNA analysis and methylation detection.
Conclusion
Clément Cassart's innovative work in the detection of DNA methylation status represents a significant advancement in molecular biology. His contributions have the potential to impact diagnostics and treatment strategies in various medical fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile